pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
pharmadog news

Browse

1,236 stories matching this filter · ← front page

★ save view↓export CSV
rangeto
sort
recentoldestsourcealpha
source
STAT808Endpoints607BioPharma Dive231onclive165Fierce Biotech75BioSpace74raps32fda press20globenewswire health
therapy area
allOncology81Cardiology27Psychiatry & CNS21Vaccines17Immunology17Rare Disease12Hepatology6
  • STAT+: Pharmalittle: We’re reading about GLP-1 drugs and knees, FDA cell and gene therapy guidance, and more
    Taking weight loss drugs for at least three years could prevent thousands of knee replacements a year, a new study found
    STAT · 1mo ago↗ source
  • Is the military fueling eating disorders?
    A brief hantavirus update, some good news about death, and more health news from Morning Rounds
    STAT · 1mo ago↗ source
  • Lilly, Ascidian link up in RNA exon editing pact
    Worth as much as $1.9 billion, the deal directs Ascidian to help Lilly find potential drugs for genetically driven kidney diseases.
    BioPharma Dive · 1mo ago↗ source
← prev
page 26 of 50
next →
20
fda recalls20
fda medwatch16
Hematology6
Pulmonology5
Infectious Disease4
Ophthalmology3
Dermatology2
  • Top ultra-processed food researchers call for sweeping policy change: ‘The system is rigged’
    A survey finds that ultra-processed foods are a cross-partisan concern. And yet policy has been slow to follow.
    STAT · 1mo ago↗ source
  • Opinion: The medical-billing AI arms race between providers and insurance
    “The financial side effects of care have become clinical ones,” writes Darshak Sanghavi.
    STAT · 1mo ago↗ source
  • Opinion: The Amish way of health care
    “Public health is going to have to talk about the Amish more and more”: Listen to STAT’s "First Opinion Podcast" on the Amish and health care.
    STAT · 1mo ago↗ source
  • Opinion: How the military may be fueling eating disorders in men
    “Much of the rhetoric, imagery, and policy messaging from the Trump administration centers on extreme masculine ideals,” First Opinion author writes.
    STAT · 1mo ago↗ source
  • STAT+: NIH cuts weakened network primed to respond to outbreaks like Ebola
    While NIH-funded centers weren’t on the front lines of virus responses like the CDC or USAID, some researchers involved in the network said the cuts have damaged relationships with experts…
    STAT · 1mo ago↗ source
  • STAT+: Trump’s Medicaid work requirements have an unwelcome surprise for some states and patients
    Advocates were already dreading Medicaid's work requirements. New rules are worse than they feared.
    STAT · 1mo ago↗ source
  • Senior NIH scientist, research fellow charged with bringing deactivated mpox virus into U.S.
    A senior NIH scientist and his research fellow were charged with smuggling vials of deactivated mpox virus into the country from Africa and lying about it.
    STAT · 1mo ago↗ source
  • Celcuity breast cancer drug misses ‘lofty’ expectations in ASCO-spotlighted trial
    Gedatolisib could “establish a new standard of care” for PIK3CA-mutated breast cancer, an investigator said, but the results nonetheless appeared to disappoint investors.
    BioPharma Dive · 1mo ago↗ source
  • Eli Lilly issues data sharing ultimatum to 340B hospitals
    Select hospitals have refused to share data to prove they’re not double-dipping drug discounts, Lilly said. Hospitals, which have until Monday to comply, are urging the government to intervene.
    BioPharma Dive · 1mo ago↗ source
  • STAT+: Longevity startup NewLimit raises $435 million ahead of first clinical trial
    Longevity startup NewLimit plans to launch its first clinical trial of a liver medicine after raising a staggering $435 million in new funding.
    STAT · 1mo ago↗ source
  • Fulcrum exploring a potential sale after FDA sidelined its sickle cell drug
    Fulcrum’s setback is the latest in a series of stumbles for the developers of sickle cell medicines, among them Pfizer, Novartis and Intellia Therapeutics.
    BioPharma Dive · 1mo ago↗ source
  • STAT+: Radiopharmaceutical shows promise in post-Pluvicto setting
    Abivax's ulcerative colitis data, Fulcrum's scrapped sickle cell drug, and more biotech news from The Readout
    STAT · 1mo ago↗ source
  • STAT+: Pharmalittle: We’re reading about a Lilly threat to 340B hospitals, Ebola vaccine funding, and more
    Lilly gave hospitals participating in a federal drug discount program five days to submit claims data or it will stop the price breaks
    STAT · 1mo ago↗ source
  • AbiVax falls as safety worries cloud ‘landmark’ immune drug results
    A handful of cancer cases reported among treatment recipients overshadowed efficacy results analysts described as “best-in-disease” and sent shares down more than 30%.
    BioPharma Dive · 1mo ago↗ source
  • How one state’s medical meal program lowered health care costs
    Medicaid work requirements, fast-tracked funding for experimental Ebola vaccines, and more health news from Morning Rounds
    STAT · 1mo ago↗ source
  • ASCO ‘26: Bispecifics vs. ADCs, a ‘RAS’ revolution and a step change in prostate cancer
    At the year’s biggest cancer meeting, a high-stakes clash between two popular drug classes erupted, and scientists made headway against a once-insurmountable foe.
    BioPharma Dive · 1mo ago↗ source
  • Why US-manufactured pharmaceutical packaging equipment matters
    As manufacturers modernize operations, the origin of their equipment is a strategic consideration.
    BioPharma Dive · 1mo ago↗ source
  • Opinion: The virtual end of the doctor’s office waiting room
    It’s time to rethink and redesign how patients enter the health care system altogether, writes emergency physician Iyesatta Massaquoi Emeli.
    STAT · 1mo ago↗ source
  • STAT+: Online care is caught in the crossfire as states crack down on corporate medicine
    Growing legislative scrutiny across multiple states targets the corporate structure underlying most direct-to-consumer telehealth businesses.
    STAT · 1mo ago↗ source
  • STAT+: Trump administration releases rules for new Medicaid work requirements
    States are racing to implement the new requirements by the start of next year.
    STAT · 1mo ago↗ source
  • STAT+: Eli Lilly warns hospitals to submit claims data in the next five days or lose their 340B drug discounts
    Eli Lilly has told more than 1,000 hospitals participating in the 340B drug discount program to submit claims data over the next five days — or lose price breaks.
    STAT · 1mo ago↗ source
  • STAT+: Global coalition to fast-track three vaccines targeting Ebola outbreak with $62 million in funding
    With no licensed vaccines available to protect against the Ebola virus currently spreading in the Congo, efforts are underway to fast-track development of at least three vaccines.
    STAT · 1mo ago↗ source